Schedule 13G ownership disclosure

FIVE PRIME THERAPEUTICS INC

Security class unavailable · CUSIP: 33830X104

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,900,000
Percent of class
6.6800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-000924
Form type
SC 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Feb 09, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub